These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8162600)

  • 1. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
    Wani MA; Xu X; Stambrook PJ
    Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic resistance to methotrexate and N-phosphonacetyl L-aspartate is induced by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kinsella AR; Fox M
    Int J Cancer; 1988 Jul; 42(1):87-93. PubMed ID: 3391708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A; Wright JA
    Oncogene; 1994 Feb; 9(2):491-9. PubMed ID: 7904743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.
    Paulson TG; Almasan A; Brody LL; Wahl GM
    Mol Cell Biol; 1998 May; 18(5):3089-100. PubMed ID: 9566927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inducible lactose operator-repressor system is functional in the whole animal.
    Wu JD; Hsueh HC; Huang WT; Liu HS; Leung HW; Ho YR; Lin MT; Lai MD
    DNA Cell Biol; 1997 Jan; 16(1):17-22. PubMed ID: 9022041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.
    Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ
    Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
    Bürkle A; Heilbronn R; zur Hausen H
    Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
    Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T
    Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permissivity for methotrexate-induced DHFR gene amplification correlates with the metastatic potential of rat adenocarcinoma cells.
    Lücke-Huhle C
    Carcinogenesis; 1994 Apr; 15(4):695-700. PubMed ID: 8149482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
    Sharma RC; Schimke RT
    Mutat Res; 1994 Jan; 304(2):243-60. PubMed ID: 7506368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc.
    Denis N; Kitzis A; Kruh J; Dautry F; Corcos D
    Oncogene; 1991 Aug; 6(8):1453-7. PubMed ID: 1886715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hamster cells with increased rates of DNA amplification, a new phenotype.
    Giulotto E; Knights C; Stark GR
    Cell; 1987 Mar; 48(5):837-45. PubMed ID: 3815526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 12-O-tetradecanoylphorbol-13-acetate on selection of drug-resistant phenotypes in rodent cells.
    Bojan F; Kinsella AR; Fox M
    IARC Sci Publ; 1984; (56):265-73. PubMed ID: 6536598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells.
    Miele M; Bonatti S; Menichini P; Ottaggio L; Abbondandolo A
    Mutat Res; 1989 May; 219(3):171-8. PubMed ID: 2567961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential susceptibility to carcinogen-induced amplification of SV40 and dhfr sequences in SV40-transformed human keratinocytes.
    Rossman TG; Wolosin D
    Mol Carcinog; 1992; 6(3):203-13. PubMed ID: 1332730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells.
    Chou CK; Liang KH; Tzeng CC; Huang GC; Chuang JI; Chang TY; Liu HS
    Life Sci; 2006 Mar; 78(16):1823-9. PubMed ID: 16274703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate].
    Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA
    Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of co-transfected expression vectors amplified by methotrexate selection in rat-1 cells.
    Ricketts MH; Vandenplas S; van der Merwe MJ; Bellstedt DU; North HM
    Eur J Cell Biol; 1991 Oct; 56(1):43-8. PubMed ID: 1666042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.